Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04443920 · ClinicalTrials.gov registry record · Phase 4
Tranexamic Acid for Total Knee Arthroscopy
A Phase 4 study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 86
- Enrollment target
NCT04443920: Completed Phase 4 study, sponsored by The Miriam Hospital.
NCT04443920 is a Phase 4 study that has completed, run by The Miriam Hospital. The registered enrollment target is 86 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04443920, a Phase 4 study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of this investigation is to determine the most effective regimen of administration of tranexamic acid to improve clinical outcome among patients undergoing total knee arthroplasty.
Primary Outcome
To compare the magnitude of lysis via lysis indexes.
Interventions
- DRUG Tranexamic acid (TXA)
- DRUG Placebo Normal Saline (NS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2021-01-08 |
| Phase | Phase 4 |
What the finished NCT04443920 record still lists
NCT04443920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Tranexamic acid (TXA) is the first listed.
NCT04443920 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04443920 about?
NCT04443920 is a clinical study titled "Tranexamic Acid for Total Knee Arthroscopy". The purpose of this investigation is to determine the most effective regimen of administration of tranexamic acid to improve clinical outcome among patients undergoing total knee arthroplasty.
What is the current status of trial NCT04443920?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 86 participants. The study started on 2019-10-29. Estimated completion is 2021-01-08.
What interventions are being tested in trial NCT04443920?
The interventions under investigation include: Tranexamic acid (TXA) (DRUG), Placebo Normal Saline (NS) (DRUG).
Who is sponsoring clinical trial NCT04443920?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04443920's enrollment target sits among peer trials
86 926th of 2000 higher than 1,073 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI